The three-year contract provides up to $24.9 million of funding for manufacturing of clinical lots, for non-clinical safety and efficacy studies, and for stability studies to further demonstrate
The proposed indication for prasugrel is for the treatment of patients with acute coronary syndromes being managed with an artery-opening procedure known as percutaneous coronary intervention. Daiichi Sankyo
The Platelet PGD test, which previously received 510 (k) clearance from the FDA holds potential to improve the safety of the blood supply by easily and quickly detecting
Tryton’s Side Branch Stent System is designed to offer a dedicated strategy for treating atherosclerotic lesions at the site of a bifurcation. The system will be available first
Under the terms of the agreement, which is subject to applicable regulatory clearances and customary conditions, Indevus will conduct and Teva will reimburse Indevus for its expenses for
Under the terms of this letter of intent (LOI), IDL will develop and manufacture the product which will be marketed and distributed by Breckenridge. The two companies plan
New data from a multi-center, randomized clinical trial indicate that the EndoBarrier is a safe, noninvasive device with excellent short-term weight loss results in morbidly obese patients. These
Nabumetone is a non-steroidal anti-inflammatory drug used to treat arthritis-related pain. Dr Reddy’s Laboratories is a pharmaceutical company that produces active pharmaceutical ingredients and intermediates, and finished dosage
Under the terms of the agreement, Shionogi will continue to have the right to use MorphoSys’s proprietary antibody library HuCAL Gold for research purposes at one of its
This program is intended to provide the technical and professional staff at Clarient with the necessary skills to provide superior clinical service using both standard and non-standard assays.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.